Sugi Predict

Sugi Predict / Compounds / SCHEMBL3285103

SCHEMBL3285103

SCHEMBL3285103

O=C(O)C1CCN(C(=O)C(F)(F)F)CC1

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.50
▸ RIPK1 Q13546 1/20 0.46
▸ EPHX1 P07099 4/20 0.44
▸ KDM1A O60341 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ EPHX2 P34913 2/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ POLB P06746 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ NOTUM Q6P988 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL977934 0.98 LMNA (0.49) LMNARIPK1EPHX1KDM1AL3MBTL1
SCHEMBL3283812 0.88 NOTUM (0.44) LMNARIPK1EPHX1NOTUM
SCHEMBL12713948 0.88 NOTUM (0.44) LMNARIPK1EPHX1NOTUM
SCHEMBL12436970 0.82 EPHX1 (0.43) LMNARIPK1EPHX1KDM1AEPHX2
SCHEMBL977933 0.82 EPHX1 (0.46) LMNARIPK1EPHX1KDM1AEPHX2
SCHEMBL28278914 0.82 GAA (0.51) LMNARIPK1EPHX1EPHX2SMN1; SMN2
SCHEMBL28223488 0.81 LMNA (0.53) LMNAL3MBTL1MAPTRAB9AGAA
SCHEMBL15935703 0.80 LMNA (0.44) LMNAL3MBTL1MAPTRAB9APOLB
SCHEMBL20955956 0.80 PDK2 (0.54) LMNA
SCHEMBL20955955 0.80 PDK2 (0.54) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 — — EP claimed
EP-1761542-A2 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS F.HOFFMANN-LA ROCHE AG (CH) 2007-03-14 — — EP claimed
WO-2005121145-A2 OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 — — WO claimed
US-20230391723-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2023-12-07 — — US disclosed
US-11702388-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2023-07-18 — — US disclosed
US-20210230116-A1 1,4-Substituted Piperidine Derivatives CEPHALON LLC 2021-07-29 — — US disclosed
CN-107847765-B 1, 4-substituted piperidine derivatives 89生物有限公司 2021-05-04 — — CN disclosed
US-10851057-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2020-12-01 — — US disclosed
EP-3310441-B1 1, 4-SUBSTITUTED PIPERIDINE DERIVATIVES 89BIO LTD (IL) 2020-07-29 — — EP disclosed
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES CEPHALON LLC 2019-05-23 — — US disclosed
US-10221135-B2 1,4-substituted piperidine derivatives 89BIO LTD (IL) 2019-03-05 — — US disclosed
US-6825043-B1 FOR DRUG SCREENING/CATALYST DESIGN UNIVERSITY OF PITTSBURGH 2004-11-30 — — US disclosed
US-20040192685-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists CAMERON KIMBERLY O (US) 2004-09-30 — — US disclosed
US-20030220494-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists CAMERON KIMBERLY O (US) 2003-11-27 — — US disclosed
US-6608203-B2 Devoid of unwanted side effects PFIZER INC. 2003-08-19 — — US disclosed
EP-1280765-A2 FLUOROUS TAGGING COMPOUNDS AND THEIR USE UNIVERSITY OF PITTSBURGH (US) 2003-02-05 — — EP disclosed
WO-2001085675-A2 FLUOROUS TAGGING COMPOUNDS AND THEIR USE UNIVERSITY OF PITTSBURGH (US) 2001-11-15 — — WO disclosed
US-20010039285-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists CAMERON KIMBERLY O (US) 2001-11-08 — — US disclosed
EP-1113007-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists PFIZER INC. (US) 2001-07-04 — — EP disclosed
WO-1997024325-A1 DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039285-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists GPER1, ESR1, ESR2 LMNA 1863/4885RIPK1 1771/4885EPHX1 173/4885
US-20190152913-A1 1,4-SUBSTITUTED PIPERIDINE DERIVATIVES FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885
US-20230391723-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885
US-20210230116-A1 1,4-Substituted Piperidine Derivatives FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885
US-20030220494-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists GPER1, ESR1, ESR2 LMNA 1863/4885RIPK1 1771/4885EPHX1 173/4885
US-20040192685-A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists GPER1, ESR1, ESR2 LMNA 1863/4885RIPK1 1771/4885EPHX1 173/4885
US-10221135-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885
US-11702388-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885
US-10851057-B2 1,4-substituted piperidine derivatives FASN, CES1, CPT1A LMNA 1574/4885RIPK1 3573/4885EPHX1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.